Relationship between plasma concentrations of morphine and its metabolites and pain in cancer patients
β Scribed by Sakurada, Tomoya ;Takada, Shinya ;Eguchi, Hisae ;Izumi, Keishiro ;Satoh, Nobunori ;Ueda, Shiro
- Publisher
- Springer
- Year
- 2010
- Tongue
- Dutch
- Weight
- 173 KB
- Volume
- 32
- Category
- Article
- ISSN
- 1573-739X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
There is growing evidence that renally-impaired patients receiving morphine therapy are at greater risk of developing opiate toxicity, due to the accumulation of an active metabolite, morphine-6-glucuronide (M6G), which is usually excreted by the kidneys. This study examined the relationships betwee
## Background: Current equianalgesic reference tables, based largely on single dose studies, give dose ratios of 1:1 to 4:1 for oral morphine to oral methadone, which possibly are inaccurate in patients with cancer pain who are exposed to multiple doses of these opioids. the purpose of this study w
The plasma concentrations of the enantiomers of halofantrine and its N-desbutyl metabolite in six patients with malaria were measured after oral administration of 3 x 750 mg doses of micronised, racemic halofantrine hydrochloride given at 6-hour intervals. Significant differences were observed betw